The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Wyzga Michael S | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Pakianathan Deepika | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Ekblom Anders | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Ekblom Anders | Director | Grant(A) | 134K | — | — |
| Feb 26, 2026 | Shames Daniel | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Shames Daniel | Director | Grant(A) | 96K | — | — |
| Feb 26, 2026 | Yoskowitz Marc J | Director | Grant(A) | 96K | — | — |
| Feb 26, 2026 | Yoskowitz Marc J | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Jacquet Pierre | Director | Grant(A) | 107K | — | — |
| Feb 26, 2026 | Jacquet Pierre | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Jenkins Annalisa | Director | Grant(A) | 107K | — | — |
| Feb 26, 2026 | Jenkins Annalisa | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Bender Jeremy | Director | Grant(A) | 66K | — | $0 |
| Feb 26, 2026 | Bender Jeremy | Director | Grant(A) | 118K | — | — |
| Feb 1, 2026 | Fox Christine Ann | Chief Financial Officer | Grant(A) | 280K | — | $0 |
| Feb 1, 2026 | Fox Christine Ann | Chief Financial Officer | Grant(A) | 316K | — | $0 |
| Feb 1, 2026 | Fox Christine Ann | Chief Financial Officer | Grant(A) | 105K | — | $0 |
| Feb 1, 2026 | Scots-Knight Denise | Chief Executive Officer, Director | Grant(A) | 345K | — | $0 |
| Feb 1, 2026 | Scots-Knight Denise | Chief Executive Officer, Director | Grant(A) | 1.0M | — | $0 |
| Feb 1, 2026 | Scots-Knight Denise | Chief Executive Officer, Director | Grant(A) | 480K | — | $0 |
| Feb 1, 2026 | Sermon Charles | General Counsel | Grant(A) | 105K | — | $0 |
| Feb 1, 2026 | Sermon Charles | General Counsel | Grant(A) | 316K | — | $0 |
| Feb 1, 2026 | Sermon Charles | General Counsel | Grant(A) | 295K | — | $0 |
| Feb 1, 2026 | Hughes-Wilson Alexandra | See Remarks | Grant(A) | 61K | — | $0 |
| Feb 1, 2026 | Hughes-Wilson Alexandra | See Remarks | Grant(A) | 184K | — | $0 |
| Feb 1, 2026 | Hughes-Wilson Alexandra | See Remarks | Grant(A) | 195K | — | $0 |
| Feb 1, 2026 | Lewicki John A. | Chief Scientific Officer | Grant(A) | 47K | — | $0 |
| Feb 1, 2026 | Lewicki John A. | Chief Scientific Officer | Grant(A) | 140K | — | $0 |
| Feb 1, 2026 | Lewicki John A. | Chief Scientific Officer | Grant(A) | 145K | — | $0 |
| Feb 5, 2025 | Jenkins Annalisa | Director | Grant(A) | 15K | — | — |
| Feb 5, 2025 | Jenkins Annalisa | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Wyzga Michael S | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Wyzga Michael S | Director | Grant(A) | 30K | — | — |
| Feb 5, 2025 | Ekblom Anders | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Ekblom Anders | Director | Grant(A) | 19K | — | — |
| Feb 5, 2025 | Pakianathan Deepika | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Yoskowitz Marc J | Director | Grant(A) | 14K | — | — |
| Feb 5, 2025 | Yoskowitz Marc J | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Jacquet Pierre | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Jacquet Pierre | Director | Grant(A) | 15K | — | — |
| Feb 5, 2025 | Shames Daniel | Director | Grant(A) | 14K | — | — |
| Feb 5, 2025 | Shames Daniel | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Bender Jeremy | Director | Grant(A) | 55K | — | $0 |
| Feb 5, 2025 | Bender Jeremy | Director | Grant(A) | 17K | — | — |
| Jan 25, 2025 | Scots-Knight Denise | Chief Executive Officer | Grant(A) | 825K | — | $0 |
| Jan 25, 2025 | Hughes-Wilson Alexandra | See Remarks | Grant(A) | 154K | — | $0 |
| Jan 25, 2025 | Sermon Charles | General Counsel | Grant(A) | 262K | — | $0 |
| Jan 25, 2025 | Fox Christine Ann | Chief Financial Officer | Grant(A) | 262K | — | $0 |
| Jan 25, 2025 | Lewicki John A. | Chief Scientific Officer | Grant(A) | 116K | — | $0 |
| Sep 13, 2024 | Hughes-Wilson Alexandra | See Remarks | Sell(S) | 84K | $4.22 | $355K |
| Sep 13, 2024 | Hughes-Wilson Alexandra | See Remarks | Sell(S) | 16K | $4.22 | $69K |
| Sep 13, 2024 | Fox Christine Ann | Chief Financial Officer | Sell(S) | 19K | $4.22 | $81K |
| Sep 13, 2024 | Sermon Charles | General Counsel | Sell(S) | 21K | $4.22 | $88K |
| Sep 13, 2024 | Lewicki John A. | Chief Scientific Officer | Sell(S) | 11K | $4.22 | $46K |
| Sep 13, 2024 | Scots-Knight Denise | Chief Executive Officer, Director | Sell(S) | 60K | $4.22 | $253K |
| Sep 12, 2024 | Hughes-Wilson Alexandra | See Remarks | Sell(S) | 40K | $4.47 | $179K |
| Sep 12, 2024 | Hughes-Wilson Alexandra | See Remarks | Sell(S) | 8K | $4.47 | $35K |
| Sep 12, 2024 | Fox Christine Ann | Chief Financial Officer | Sell(S) | 9K | $4.47 | $41K |
| Sep 12, 2024 | Sermon Charles | General Counsel | Sell(S) | 10K | $4.47 | $45K |
| Sep 12, 2024 | Lewicki John A. | Chief Scientific Officer | Sell(S) | 5K | $4.47 | $23K |
| Sep 12, 2024 | Scots-Knight Denise | Chief Executive Officer, Director | Sell(S) | 29K | $4.47 | $128K |
| Sep 11, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 93K | $1.40 | $131K |
| Sep 11, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 40K | — | $0 |
| Sep 11, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 75K | $1.01 | $76K |
| Sep 11, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 93K | $1.40 | $131K |
| Sep 11, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 75K | $1.01 | $76K |
| Sep 11, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 40K | — | $0 |
| Sep 11, 2024 | Scots-Knight Denise | Chief Executive Officer, Director | Option exercise(M) | 188K | — | $0 |
| Sep 11, 2024 | Scots-Knight Denise | Chief Executive Officer, Director | Option exercise(M) | 188K | — | $0 |
| Sep 11, 2024 | Lewicki John A. | Chief Scientific Officer | Option exercise(M) | 46K | — | $0 |
| Sep 11, 2024 | Lewicki John A. | Chief Scientific Officer | Option exercise(M) | 46K | — | $0 |
| Sep 11, 2024 | Fox Christine Ann | Chief Financial Officer | Option exercise(M) | 60K | — | $0 |
| Sep 11, 2024 | Fox Christine Ann | Chief Financial Officer | Option exercise(M) | 60K | — | $0 |
| Sep 11, 2024 | Sermon Charles | General Counsel | Option exercise(M) | 66K | — | $0 |
| Sep 11, 2024 | Sermon Charles | General Counsel | Option exercise(M) | 66K | — | $0 |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 43K | $0.94 | $41K |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 2K | $3.87 | $8K |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 12K | $2.72 | $34K |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 39K | $1.31 | $51K |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 6K | $1.84 | $12K |
| Aug 22, 2024 | Pakianathan Deepika | Director | Sell(S) | 105K | $4.43 | $466K |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 2K | $3.00 | $5K |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 55K | — | $0 |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 15K | — | $0 |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 55K | — | $0 |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 32K | — | $0 |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 6K | — | $0 |
| Aug 22, 2024 | Pakianathan Deepika | Director | Option exercise(M) | 11K | — | $0 |
| Jun 26, 2024 | Hughes-Wilson Alexandra | See Remarks | Sell(S) | 23K | $3.39 | $78K |
| Jun 26, 2024 | Scots-Knight Denise | Chief Executive Officer, Director | Sell(S) | 92K | $3.39 | $313K |
| Jun 26, 2024 | Fox Christine Ann | Chief Financial Officer | Sell(S) | 29K | $3.39 | $100K |
| Jun 26, 2024 | Lewicki John A. | Chief Scientific Officer | Sell(S) | 17K | $3.39 | $57K |
| Jun 26, 2024 | Sermon Charles | General Counsel | Sell(S) | 32K | $3.39 | $109K |
| Jun 25, 2024 | Hughes-Wilson Alexandra | See Remarks | Sell(S) | 10K | $3.69 | $37K |
| Jun 25, 2024 | Scots-Knight Denise | Chief Executive Officer, Director | Sell(S) | 41K | $3.69 | $150K |
| Jun 25, 2024 | Fox Christine Ann | Chief Financial Officer | Sell(S) | 13K | $3.69 | $48K |
| Jun 25, 2024 | Lewicki John A. | Chief Scientific Officer | Sell(S) | 7K | $3.69 | $27K |
| Jun 25, 2024 | Sermon Charles | General Counsel | Sell(S) | 14K | $3.69 | $52K |
| Jun 21, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 60K | — | $0 |
| Jun 21, 2024 | Hughes-Wilson Alexandra | See Remarks | Option exercise(M) | 60K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).